Deluqing

Noni Fruit Enzyme

Shenzhen Deyintang Biotechnology Co., Ltd.
Human Otc Drug
NDC 82570-015

Deluqing also known as Noni Fruit Enzyme is a human otc drug labeled by 'Shenzhen Deyintang Biotechnology Co., Ltd.'. National Drug Code (NDC) number for Deluqing is 82570-015. This drug is available in dosage form of Powder. The names of the active, medicinal ingredients in Deluqing drug includes Amino Acids - 5 g/100g Avocado - 10 g/100g Banana - 3 g/100g Beet Juice - 2 g/100g Bromelains - 5 g/100g Cabbage - 1 g/100g Daikon - 2 g/100g Fu Ling - 3 g/100g Guava - 2 g/100g Lilium Lancifolium Whole - 3 g/100g and more. The currest status of Deluqing drug is Active.

Drug Information:

Drug NDC:	82570-015
The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
Proprietary Name:	Deluqing
Also known as the trade name. It is the name of the product chosen by the labeler.
Product Type:	Human Otc Drug
Indicates the type of product, such as Human Prescription Drug or Human OTC Drug. This data element corresponds to the “Document Type” of the SPL submission for the listing.
Non Proprietary Name:	Noni Fruit Enzyme
Also known as the generic name, this is usually the active ingredient(s) of the product.
Labeler Name:	Shenzhen Deyintang Biotechnology Co., Ltd.
Name of Company corresponding to the labeler code segment of the ProductNDC.
Dosage Form:	Powder
The translation of the DosageForm Code submitted by the firm. There is no standard, but values may include terms like `tablet` or `solution for injection`.The complete list of codes and translations can be found www.fda.gov/edrls under Structured Product Labeling Resources.
Status:	Active
FDA does not review and approve unfinished products. Therefore, all products in this file are considered unapproved.
Substance Name:	AMINO ACIDS - 5 g/100g AVOCADO - 10 g/100g BANANA - 3 g/100g BEET JUICE - 2 g/100g BROMELAINS - 5 g/100g CABBAGE - 1 g/100g DAIKON - 2 g/100g FU LING - 3 g/100g GUAVA - 2 g/100g LILIUM LANCIFOLIUM WHOLE - 3 g/100g Load more... MOMORDICA CHARANTIA WHOLE - 2 g/100g NONI FRUIT - 20 g/100g PEAR - 5 g/100g PLATYCODON GRANDIFLORUM ROOT - 10 g/100g SIRAITIA GROSVENORII WHOLE - 4 g/100g SORGHUM - 1 g/100g SOY PROTEIN - 1 g/100g TOLUENE - 6 g/100g
This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted.
Route Details:	TOPICAL
The translation of the Route Code submitted by the firm, indicating route of administration. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.

Marketing Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.

Marketing Category:	UNAPPROVED DRUG OTHER
Product types are broken down into several potential Marketing Categories, such as New Drug Application (NDA), Abbreviated New Drug Application (ANDA), BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
Marketing Start Date:	22 Feb, 2022
This is the date that the labeler indicates was the start of its marketing of the drug product.
Marketing End Date:	04 May, 2026
This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached.
Listing Expiration Date:	31 Dec, 2023
This is the date when the listing record will expire if not updated or certified by the firm.

OpenFDA Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.

Manufacturer Name:	Shenzhen Deyintang Biotechnology Co., Ltd.
Name of manufacturer or company that makes this drug product, corresponding to the labeler code segment of the NDC.
Original Packager:	Yes
Whether or not the drug has been repackaged for distribution.
NUI:	N0000175797 M0000922 N0000185371 N0000175629 N0000184306 M0000728 M0006342 N0000185015 M0022575
Unique identifier applied to a drug concept within the National Drug File Reference Terminology (NDF-RT).
UNII:	0O72R8RF8A SDS87L369F 4AJZ4765R9 IOZ32L9H3O U182GP2CF3 GW0W1Y9I97 86R5J6D01D XH37TWY5O4 74O70D6VG0 079XQO23D9 Load more... 83M15WOS0F 7829X3G2X5 2ZN8DWC0YF 2DF0NS0O2Z Q1W0T771NI CUL9PN8ELJ R44IWB3RN5 3FPU23BG52
Unique Ingredient Identifier, which is a non-proprietary, free, unique, unambiguous, non-semantic, alphanumeric identifier based on a substance’s molecular structure and/or descriptive information.
Pharmacologic Class EPC:	Amino Acid Hypertonic Solution [EPC] Non-Standardized Food Allergenic Extract [EPC]
Established pharmacologic class associated with an approved indication of an active moiety (generic drug) that the FDA has determined to be scientifically valid and clinically meaningful. Takes the form of the pharmacologic class, followed by `[EPC]` (such as `Thiazide Diuretic [EPC]` or `Tumor Necrosis Factor Blocker [EPC]`.
Pharmacologic Class PE:	Increased Histamine Release [PE] Cell-mediated Immunity [PE]
Physiologic effect or pharmacodynamic effect—tissue, organ, or organ system level functional activity—of the drug’s established pharmacologic class. Takes the form of the effect, followed by `[PE]` (such as `Increased Diuresis [PE]` or `Decreased Cytokine Activity [PE]`.
Pharmacologic Class CS:	Amino Acids [CS] Allergens [CS] Dietary Proteins [CS] Vegetable Proteins [CS]
Chemical structure classification of the drug product’s pharmacologic class. Takes the form of the classification, followed by `[Chemical/Ingredient]` (such as `Thiazides [Chemical/Ingredient]` or `Antibodies, Monoclonal [Chemical/Ingredient].
Pharmacologic Class:	Allergens [CS] Amino Acid Hypertonic Solution [EPC] Amino Acids [CS] Cell-mediated Immunity [PE] Dietary Proteins [CS] Fruit Proteins [EXT] Increased Histamine Release [PE] Non-Standardized Food Allergenic Extract [EPC] Vegetable Proteins [CS]
These are the reported pharmacological class categories corresponding to the SubstanceNames listed above.

Packaging Information:

Package NDC	Description	Marketing Start Date	Marketing End Date	Sample Available
82570-015-01	4 g in 1 POUCH (82570-015-01)	22 Feb, 2022	N/A	No
Package NDC number, known as the NDC, identifies the labeler, product, and trade package size. The first segment, the labeler code, is assigned by the FDA. Description tells the size and type of packaging in sentence form. Multilevel packages will have the descriptions concatenated together.

Other medicines with the same generic name

Deluqing

Noni Fruit Enzyme

Powder
Shenzhen Deyintang Biotechnology Co., Ltd.
NDC: 82570-015

Purpose:

Health care

Product Elements:

Deluqing noni fruit enzyme guava guava beet juice beet juice momordica charantia whole momordica charantia whole daikon daikon sorghum sorghum soy protein soy protein avocado avocado toluene toluene siraitia grosvenorii whole siraitia grosvenorii whole noni fruit noni fruit cabbage cabbage platycodon grandiflorum root platycodon grandiflorum root banana banana amino acids amino acids bromelains bromelains pear pear lilium lancifolium whole lilium lancifolium whole fu ling fu ling cherry apple lemon

Indications and Usage:

Please eat according to the recommended amount, it is not beneficial to eat too much.

Warnings:

1.please avoid children taking it by themselves. 2.please eat according to the recommended amount, it is not beneficial to eat too much. 3.please keep in a cool and dry place and avoid direct sunlight and high temperature.

Dosage and Administration:

How to eat 1 sachet each time, add 150-200ml of cool white water to brew, stir well and eat.

Package Label Principal Display Panel:

Label

Comments/ Reviews:

* Data of this site is collected from www.fda.gov. This page is for informational purposes only. Always consult your physician with any questions you may have regarding a medical condition.